Physician profile
Rex Ajayi
NPI 1801899539
$1,669.48
in general payments reported to CMS, 2019-2025
25 companies · $287 in 2025
The $287 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $468 · 2020: $168 · 2021: $565 · 2022: $181 · 2025: $287.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $287.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $287.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $328.78 | 2019-2021 | |
| Myovant Sciences INC. | $255.80 | 2021-2022 | |
| Myriad Genetic Laboratories, INC. | $252.25 | 2021-2022 | |
| Neotract INC. | $121.13 | 2019 | |
| Antares Pharma, INC. | $93.65 | 2019-2022 | |
| Medtronic, INC. | $75.26 | 2021-2025 | Interstim |
| Sumitomo Pharma America, INC. | $63.18 | 2025 | Gemtesa |
| Boston Scientific Corporation | $57.82 | 2019-2021 | |
| Profound Medical Corp. | $54.94 | 2025 | Tulsa-Pro |
| Abbvie INC. | $33.06 | 2025 | |
| C. R. Bard, INC. & Subsidiaries | $31.01 | 2019 | |
| Janssen Biotech, INC. | $30.35 | 2019 | |
| Tolmar, INC. | $28.69 | 2025 | Eligard, Jatenzo |
| Endo Pharmaceuticals INC. | $27.06 | 2019-2020 | |
| Laborie Medical Technologies Corp. | $23.99 | 2025 | Endosheath Technology |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Blue Earth Diagnostics | $23.79 | 2020 | |
| Pfizer INC. | $23.67 | 2020 | |
| Cook Medical LLC | $23.53 | 2021 | |
| Melinta Therapeutics, LLC | $18.84 | 2025 | Rezzayo, Kimyrsa |
| Urovant Sciences INC | $18.66 | 2021 | |
| Convatec INC. | $18.15 | 2022 | |
| Axonics, INC. | $17.44 | 2021 | |
| Procept Biorobotics Corporation | $17.08 | 2025 | |
| Avadel Specialty Pharmaceuticals, LLC | $16.85 | 2019 | |
| Medtronic USA, INC. | $14.50 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rex Ajayi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.